{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/686e5d928d3d6839f4faaadc/68b07efd46792aead138904e?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Migration of Clinical Trial Data - The Zelta Podcast - Episode 4","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/686e5d928d3d6839f4faaadc/1756397292706-89f66361-f053-4c6a-92dd-1c22eed5ad89.jpeg?height=200","description":"<p>Migrating clinical studies to a new platform required careful planning and is the focus of episode four in the Zelta Podcast series. We will be looking at the considerations for migrating clinical studies.&nbsp;</p><p><br></p><p>Also covered are the reasons for and against a migration, the next step once a migration has been agreed upon, who builds the study, and what success looks like.</p><p><br></p><p>Our guests are:</p><p><br></p><ul><li>Anjali Agrawal, Senior Life Sciences Consultant at Zelta by Merative</li><li>Isaac Erickson, Vice President of Consulting Services at Zelta by Merative</li></ul>","author_name":"GlobalData Marketing Solutions"}